Purpose This randomized, controlled, multicenter, open-label, phase III study compared
docetaxel versus paclitaxel in patients with advanced breast cancer that had progressed …

Docetaxel (Taxotere®), a cytotoxic taxane, is an antimicrotubule agent effective in the
treatment of patients with breast cancer. The clinical profile of docetaxel as an effective …

PURPOSE: This phase III study compared docetaxel and doxorubicin in patients with
metastatic breast cancer who had received previous alkylating agent–containing …

PURPOSE: This pilot phase II study investigated the efficacy and toxicity of docetaxel with
doxorubicin and cyclophosphamide (TAC) as first-line chemotherapy for anthracycline-naive …

Abstract Learning Objectives After completing this course, the reader will be able to: Identify
the response rates to weekly paclitaxel and docetaxel for metastatic breast cancer. Name …

Purpose To evaluate whether a relationship exists between docetaxel dose and clinical
response in the treatment of patients with advanced breast cancer. Patients and Methods …

Purpose: This randomized, multicenter, phase III study compared doxorubicin and docetaxel
(AT) with doxorubicin and cyclophosphamide (AC) as first-line chemotherapy (CT) in …

Background A phase II randomised trial was conducted to evaluate the tolerability and
activity of weekly or 3-weekly docetaxel in patients with metastatic breast cancer. Patients …

PURPOSE: This phase III study compared docetaxel with mitomycin plus vinblastine (MV) in
patients with metastatic breast cancer (MBC) progressing despite previous anthracycline …

PURPOSE To evaluate the efficacy and safety of docetaxel in patients with paclitaxel-
resistant metastatic breast cancer (MBC). PATIENTS AND METHODS Docetaxel (100 …